For $2 million, Reddy’s Laboratories Ltd purchases a 6.46% share in the Israeli biotech company Edity Therapeutics. [Representational image only Credit : Unsplash/] Courtesy : News Agency ; 29/12/2023
Thu. Jul 4th, 2024
For $2 million, Reddy’s Laboratories Ltd purchases a 6.46% share in the Israeli biotech company Edity Therapeutics. [Representational image only Credit : Unsplash/] Courtesy : News Agency ; 29/12/2023